Dialkyldithiocarbamates injected into mice 0.5 h prior to alloxan prot
ected dose-dependently against the diabetogenic action of alloxan, and
increased blood glucose levels at the time of alloxan injection. Furt
hermore, they exhibited anti-oxidative properties in vitro such as inh
ibition of lipid peroxidation, removal of hydrogen peroxide and reduct
ion of the stable free radical, 1,1-diphenyl-2-picrylhydrazyl (DPPH).
These results suggest that dialkyldithiocarbamates protect against the
development of alloxan-induced diabetes by the indirect mechanism of
producing hyperglycemia at the time of alloxan injection and possibly
by their anti-oxidative effects as well.